智通财经APP获悉，东阳光长江药业(01558)早盘涨超5%，截至发稿，涨4.62%，报14.96港元，成交额1473.08万港元。
消息面上，东阳光长江药业公布，有关母公司广东东阳光药业以换股方式将公司吸收合并，并以介绍形式在联交所主板上市的最新资料。至今，前提条件1及3已达成，而仅前提条件2(即就(以介绍方式)上市取得联交所上市委员会、中证监国际合作部及其他所需主管机关的批准或向其备案，以及批准要约人H股根据上市于联交所买卖)尚未全面达成。
此外，三生制药近期刷新国产创新药BD纪录。据悉，2024年11月25日，东阳光药发布公告，授予三生制药附属公司沈阳三生苯磺酸克立福替尼在中国关于特定适应症的独家商业化权益。此次BD合作也是东阳光药继与Apollo Therapeutics达成9亿美元BD交易后，在2024年11月份以来的第二个License-out合作交易。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.